Concepedia
Statistics
Publications
23
Citations
2K
H-Index
19
Active since
1999
Affiliations
Peter MacCallum Cancer Centre(Current)
The University of Melbourne
Princess Alexandra Hospital
Monash University
Liverpool Hospital
Mark Shaw is an author at Peter MacCallum Cancer Centre specializing in medicine, radiation therapy, and oncology.
Publications per year
1999–2024
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
David Ball, Shalini Vinod, Scott Babington et al. · The Lancet Oncology · 2019 · 584 citations
Medicine, Oncology, Radiation Oncology +13
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva, Mathias Bressel, Declan G. Murphy et al. · European Urology · 2018 · 323 citations
Medicine, Radiation Oncology, Urology +15
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
Shankar Siva, Mathias Bressel, Simon Wood et al. · European Urology · 2021 · 149 citations
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva, Daniel Pham, Tomas Kron et al. · British Journal of Urology · 2017 · 119 citations
Medicine, Oncology, Radiation Oncology +17
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom et al. · The Lancet Oncology · 2024 · 105 citations
1–5 of 23